Patent Assignment
Reel/Frame 031626/0604
Corrective Assignment to Correct the Assignor and Assignee Information Previously Recorded on Reel 031571 Frame 0676. Assignor(S) Hereby Confirms the Correct Assignor Is Malvern Consulting Group, Inc. and the Correct Assignee Is Recro Pharma, Inc..
Recorded: 2013-11-12
Pages: 6
Assignor
MALVERN CONSULTING GROUP, INC.
Executed: 2013-10-23
Assignee
RECRO PHARMA, INC.
490 LAPP ROAD, MALVERN, PENNSYLVANIA, 19355
Covered Property
(1)
Oral Mucosal Dexmedetomidine Compositions and Methods of Use Thereof
Application:
12/781,628 →
Publication:
US 2011/0021588
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 8, 2013
From: RECRO PHARMA, INC.
To: MALVERN CONSULTING GROUP, INC.
Reel/Frame 031571/0676 →
Security Interest
Apr 14, 2015
From: RECRO PHARMA, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 035403/0197 →
Release of Security Interest
Nov 17, 2017
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: RECRO PHARMA, INC.
Reel/Frame 044481/0907 →
Assignment of Assignor's Interest
Jan 30, 2020
From: RECRO PHARMA, INC.
To: BAUDAX BIO, INC.
Reel/Frame 051671/0536 →
Security Interest
Jun 10, 2020
From: BAUDAX BIO N.A. LLC; BAUDAX BIO LIMITED; BAUDAX BIO, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052891/0590 →